Skip to main content
. 2020 Nov 12;44(1):91–99. doi: 10.1002/clc.23510

TABLE 2.

Clinical outcomes of the patients divided by the presence of complete atrioventricular block

All patients Anterior STEMI Nonanterior STEMI
CAVB (+) (n = 81) CAVB (−) (n = 1214) p value CAVB (+) (n = 11) CAVB (−)(n = 629) p value CAVB (+) (n = 70) CAVB (−) (n = 585) p value
Complications during hospitalization
Cardiogenic shock, n (%) 20 (24) 85 (7) <0.05 7 (64) 57 (9) <0.05 13 (19) 28 (5) <0.05
Decompensated heart failure, n (%) 31 (38) 175 (14) <0.05 11 (100) 128 (20) <0.05 20 (29) 47 (8) <0.05
Ventricular arrhythmias, n (%) 11 (14) 113 (9) 0.21 5 (45) 66 (10) <0.05 6 (9) 47 (8) 0.88
Device implantation, n (%) 4 (5) 14 (1) <0.05 1 (9) 7 (1) 0.13 3 (4) 7 (1) 0.08
PPM, n (%) 2 (2) 4 (1) <0.05 1 (9) 1 (1) <0.05 1 (1) 3 (1) 0.36
ICD, n (%) 1 (1) 9 (1) 0.48 0 (0) 5 (1) 1.00 1 (1) 4 (1) 0.43
CRT, n (%) 1 (1) 1 (1) 0.12 0 (0) 1 (1) 1.00 1 (1) 0 (0) 0.11
Short‐term outcomes
In‐hospital mortality, n (%) 9 (11) 59 (5) <0.05 6 (55) 42 (7) <0.05 3 (4) 17 (3) 0.46
30‐day mortality, n (%) 8 (10) 59 (5) 0.05 5 (46) 41 (7) <0.05 3 (4) 18 (3) 0.49
Long‐term outcomes
All‐cause death, n (%) 30 (37) 233 (19) <0.05 9 (82) 128 (20) <0.05 21 (30) 105 (18) <0.05
MACCE, n (%) 26 (32) 268 (22) <0.05 9 (82) 159 (25) <0.05 17 (24) 109 (19) 0.26
Cardiac death, n (%) 14 (18) 112 (9) <0.05 8 (73) 74 (12) <0.05 6 (9) 38 (7) 0.45
Nonfatal MI, n (%) 4 (5) 64 (5) 1.00 0 (0) 27 (4) 1.00 4 (6) 37 (6) 1.00
Nonfatal stroke, n (%) 5 (6) 71 (6) 0.90 0 (0) 34 (5) 1.00 5 (7) 37 (6) 0.80
Hospitalization due to HF, n (%) 6 (7) 88 (7) 0.96 2 (18) 59 (9) 0.28 4 (6) 29 (5) 0.77

Note: Data are presented as frequency (percentage) for categorical variables. STEMI indicates ST‐segment elevation myocardial infarction.

Abbreviations: CAVB, complete atrioventricular block; CRT, cardiac resynchronization therapy; HF, heart failure; ICD, implantable cardioverter defibrillator; MACCE, major adverse cardiocerebrovascular event; MI, myocardial infarction; PPM, permanent pacemaker.